InvestorsHub Logo
Followers 664
Posts 46928
Boards Moderated 2
Alias Born 03/30/2009

Re: None

Friday, 01/20/2017 1:29:13 PM

Friday, January 20, 2017 1:29:13 PM

Post# of 48316
Somewhat (in)directly related to OncoSec:

Bristol-Myers shares fall on lung cancer timeline setback

(Reuters) - Shares of Bristol-Myers Squibb (BMY.N) fell nearly 10 percent on Friday following Thursday's announcement that it would not seek accelerated approval of its immunotherapy drug combination in first-line lung cancer, further solidifying Merck & Co's (MRK.N) leading position in the burgeoning immuno-oncolgy field.


https://finance.yahoo.com/news/bristol-myers-shares-fall-lung-171405197.html

$ONCS

Success is never final; failure is never fatal. It's courage that counts.--John Wooden (1910-2010)

Courage is being scared to death, but saddling up anyway.--John Wayne (1907-1979)

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ONCSQ News